These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
374 related items for PubMed ID: 17582802
21. Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice. Hirakawa H, Yokoyama Y, Yoshida H, Mizunuma H. J Ovarian Res; 2014 Jan 10; 7():4. PubMed ID: 24410765 [Abstract] [Full Text] [Related]
32. Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells. Wolfesberger B, Walter I, Hoelzl C, Thalhammer JG, Egerbacher M. Res Vet Sci; 2006 Jun 15; 80(3):308-16. PubMed ID: 16182328 [Abstract] [Full Text] [Related]
33. Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. Kuipers GK, Slotman BJ, Wedekind LE, Stoter TR, Berg Jv, Sminia P, Lafleur MV. Int J Radiat Biol; 2007 Oct 15; 83(10):677-85. PubMed ID: 17729162 [Abstract] [Full Text] [Related]
35. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium. Scoditti E, Massaro M, Carluccio MA, Distante A, Storelli C, De Caterina R. Cardiovasc Res; 2010 May 01; 86(2):302-10. PubMed ID: 20032081 [Abstract] [Full Text] [Related]
36. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice. Sawada I, Hashimoto K, Sawada K, Kinose Y, Nakamura K, Toda A, Nakatsuka E, Yoshimura A, Mabuchi S, Fujikawa T, Itai A, Kimura T. Int J Gynecol Cancer; 2016 May 01; 26(4):610-8. PubMed ID: 26905334 [Abstract] [Full Text] [Related]
38. Modulation of cell growth and PPARgamma expression in human colorectal cancer cell lines by ciglitazone. Yaacob NS, Darus HM, Norazmi MN. Exp Toxicol Pathol; 2008 Sep 01; 60(6):505-12. PubMed ID: 18579355 [Abstract] [Full Text] [Related]
39. Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells. Vignati S, Albertini V, Rinaldi A, Kwee I, Riva C, Oldrini R, Capella C, Bertoni F, Carbone GM, Catapano CV. Neoplasia; 2006 Oct 01; 8(10):851-61. PubMed ID: 17032502 [Abstract] [Full Text] [Related]
40. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism]. Zhang M, Zou P, Bai M, Tao XN, Jin Y, Guo R. Zhonghua Yi Xue Za Zhi; 2003 Jul 10; 83(13):1169-72. PubMed ID: 12921638 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]